Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: a meta-analysis
W Wen, C Chen, J Tang, C Wang, M Zhou… - Annals of …, 2022 - Taylor & Francis
Background The coronavirus disease (COVID-19) epidemic has not been completely
controlled. Although great achievements have been made in COVID-19 research and many …
controlled. Although great achievements have been made in COVID-19 research and many …
Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis
Background: To date, coronavirus disease 2019 (COVID-19) becomes increasingly fierce
due to the emergence of variants. Rapid herd immunity through vaccination is needed to …
due to the emergence of variants. Rapid herd immunity through vaccination is needed to …
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis
A Choi, M Koch, K Wu, L Chu, LZ Ma, A Hill, N Nunna… - Nature medicine, 2021 - nature.com
The emergence of SARS-CoV-2 variants of concern (VOCs) and variants of interest (VOIs)
with decreased susceptibility to neutralization has generated interest in assessments of …
with decreased susceptibility to neutralization has generated interest in assessments of …
Efficacy of SARS-CoV-2 vaccines and the dose–response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled …
ZR Yang, YW Jiang, FX Li, D Liu, TF Lin… - The Lancet …, 2023 - thelancet.com
Background The efficacy of SARS-CoV-2 vaccines in preventing severe COVID-19 illness
and death is uncertain due to the rarity of data in individual trials. How well the antibody …
and death is uncertain due to the rarity of data in individual trials. How well the antibody …
Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis
There is a significant research gap in meta-analysis on the efficacy and safety of coronavirus
disease 2019 (COVID-19) vaccines. This study analyzed the efficacy of COVID-19 vaccines …
disease 2019 (COVID-19) vaccines. This study analyzed the efficacy of COVID-19 vaccines …
Cutaneous findings following COVID‐19 vaccination: review of world literature and own experience
T Gambichler, S Boms, L Susok… - Journal of the …, 2022 - Wiley Online Library
There is growing evidence that not only the novel coronavirus disease (COVID‐19) but also
the COVID‐19 vaccines can cause a variety of skin reactions. In this review article, we …
the COVID‐19 vaccines can cause a variety of skin reactions. In this review article, we …
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID‐19 vaccines in Hong Kong
CKP Mok, CA Cohen, SMS Cheng, C Chen… - …, 2022 - Wiley Online Library
Background and objective Few head‐to‐head evaluations of immune responses to different
vaccines have been reported. Methods Surrogate virus neutralization test (sVNT) antibody …
vaccines have been reported. Methods Surrogate virus neutralization test (sVNT) antibody …
Safety and efficacy of COVID‐19 vaccines: A systematic review and meta‐analysis of controlled and randomized clinical trials
J Beladiya, A Kumar, Y Vasava… - Reviews in medical …, 2024 - Wiley Online Library
Vaccines against coronavirus disease 2019 (COVID‐19) have been discovered within a
very small duration of time as compared to the traditional way for the development of …
very small duration of time as compared to the traditional way for the development of …
Adverse events following COVID-19 vaccination: A systematic review and meta-analysis
H Kouhpayeh, H Ansari - International Immunopharmacology, 2022 - Elsevier
Background High speed of COVID-19 vaccination has raised some concerns about the
safety of the new vaccines. It is of a great importance to perform a review of the safety and …
safety of the new vaccines. It is of a great importance to perform a review of the safety and …
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial
L Chu, K Vrbicky, D Montefiori, W Huang… - Nature medicine, 2022 - nature.com
Rising breakthrough infections of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) in previously immunized individuals have raised concerns for the need for a booster …
CoV-2) in previously immunized individuals have raised concerns for the need for a booster …